Diabetes drug may elevate bladder cancer riskJuly 4th, 2012 - 4:25 pm ICT by IANS
Toronto, July 4 (IANS) Pioglitazone, a drug commonly prescribed for type 2 diabetes, may also elevate bladder cancer risk, says a new Canadian research.
In a bid to link pioglitazone and bladder cancer, researchers conducted a systematic review and analysis of clinical trials and observational studies involving over 2.6 million patients.
“We observed an increased risk of bladder cancer associated with the use of thiazolidinediones,” writes Jeffrey Johnson from the School of Public Health, University of Alberta and study co-author, the Canadian Medical Association Journal reports.
Thiazolidinediones, including Pioglitazone, introduced in the late 1990s, are also known as glitazones, a class of drugs used in the treatment of type 2 diabetes, according to an Alberta statement.
“In particular, use of pioglitazone was associated with an increased risk of bladder cancer based on a pooled estimate from three cohort studies involving more than 1.7 million individuals,” adds Johnson.
The researchers also looked at a possible association with rosiglitazone, another type of thiazolidinedione, but did not see an effect.
- Drug used to treat type 2 diabetes linked to heart problems - Mar 18, 2011
- No link between diabetes drug and rise in heart attacks - Jun 30, 2010
- Popular diabetes drugs 'increase risk for fractures in patients' - Jul 30, 2010
- Diabetes drug may boost power of anti-depressants - May 03, 2012
- Diabetes drug 'increases heart failure risk' - Aug 21, 2009
- Heart risks linked to diabetes drug - Jun 29, 2010
- Diabetes or lipid-lowering medications may help treat addiction - Apr 06, 2011
- Experts review link between diabetes and cancer - Jun 17, 2010
- Diabetes drugs may lead to vision-threatening complication - Apr 03, 2009
- Diabetes drug can raise heart disease risk by 25 percent - Mar 18, 2011
- Popular diabetes drugs could elevate risk of heart failure and death - Dec 04, 2009
- Loss of cell powerhouses linked to Parkinson's - Oct 07, 2010
- Diabetes increases risk of cancer, say experts - Jun 17, 2010
- The Diabetes Drugs, Avandia and Actos, Have The Same Amount of Risks - Aug 29, 2010
- Avoiding or controlling diabetes may cut cancer risk, mortality - Apr 04, 2011
Tags: bladder cancer risk, canadian medical association, canadian medical association journal, cancer researchers, clinical trials, co author, cohort studies, diabetes drug, jeffrey johnson, medical association journal, observational studies, pioglitazone, possible association, public health university, school of public health, thiazolidinedione, thiazolidinediones, treatment of type 2 diabetes, type 2 diabetes, university of alberta